Literature DB >> 2232913

Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the U.S., 1977-1986: evidence for an inherently susceptible population subset.

J E Riggs1.   

Abstract

Age-adjusted mortality rates for amyotrophic lateral sclerosis (ALS) for men and women in the United States from 1977 to 1986 were determined and subjected to longitudinal Gompertzian analysis. The exponential decline in the rate of increase of age-adjusted ALS mortality rates after age 55 years is most consistent with the existence of an inherently susceptible population subset that is decreasing faster than the general population. In the U.S. between 1977 and 1986, annual age-adjusted ALS mortality rate distributions were determined by a common fixed intersect point (for men, the death rate at age 46.38 years was 0.91/100,000; for women, the death rate at age 45.85 years was 0.46/100,000); and an environmental factor that varied erratically during the decade by a factor of 7.21 for men and 11.64 for women. On the average, the U.S. environment during this period was 4.33 times more conducive to mortality from ALS in men than in women. Overall ALS mortality between 1977 and 1986 increased 46% and 49% for men and women, respectively. The common fixed intersect point in mortality rate distributions suggests that these increases were real and not merely the result of improved diagnosis and/or better reporting. The overall increase in ALS mortality most likely results from an effective increase in the susceptible population subset due to increasing life expectancy, rather than to environmental factors. That is, as life expectancy increases, more of the susceptible population subset live long enough to express the disease.

Entities:  

Mesh:

Year:  1990        PMID: 2232913     DOI: 10.1016/0047-6374(90)90149-a

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  11 in total

1.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

Review 2.  Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis.

Authors:  G C Román
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

3.  Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.

Authors:  Paul H Gordon; Fanny Artaud; Albertine Aouba; Françoise Laurent; Vincent Meininger; Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2011-06-15       Impact factor: 8.082

Review 4.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

Authors:  Peter M Andersen; Ammar Al-Chalabi
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

Review 5.  C9orf72-Related Neurodegenerative Diseases: From Clinical Diagnosis to Therapeutic Strategies.

Authors:  Stefania Zampatti; Cristina Peconi; Rosa Campopiano; Stefano Gambardella; Carlo Caltagirone; Emiliano Giardina
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

6.  Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.

Authors:  A M Chancellor; R J Swingler; H Fraser; J A Clarke; C P Warlow
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

7.  Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation.

Authors:  S Neilson; I Robinson; A Alperovitch
Journal:  J Neurol       Date:  1994-06       Impact factor: 4.849

8.  Encephalitis-associated hospitalizations among American Indians and Alaska Natives.

Authors:  Jason M Mehal; Robert C Holman; Neil M Vora; Jesse Blanton; Paul H Gordon; James E Cheek
Journal:  Am J Trop Med Hyg       Date:  2014-02-10       Impact factor: 2.345

Review 9.  Smoking may be considered an established risk factor for sporadic ALS.

Authors:  Carmel Armon
Journal:  Neurology       Date:  2009-11-17       Impact factor: 9.910

Review 10.  Risk factors for amyotrophic lateral sclerosis.

Authors:  Caroline Ingre; Per M Roos; Fredrik Piehl; Freya Kamel; Fang Fang
Journal:  Clin Epidemiol       Date:  2015-02-12       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.